Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Kennethcix by Kennethcix
March 25, 2026
in Analysis, Commodities, Mergers & Acquisitions, Penny Stocks
0
Coeur Mining Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Market experts are offering sharply contrasting recommendations for Coeur Mining, underscoring the uncertainty surrounding the company’s recent major acquisition. Cantor Fitzgerald has upgraded its rating from Hold to Buy, setting a price target of $20, following a recent share price decline. In a starkly different assessment, CIBC rates the stock as an Outperformer with a $40 price target. This wide discrepancy primarily reflects divergent opinions on the integration and value of Coeur’s newly acquired Canadian assets from New Gold.

Extended Mine Life and Substantial Resources

The catalyst for this renewed analytical focus is Coeur’s first comprehensive operational update since finalizing the New Gold transaction. A key revelation is the inaugural resource estimate for the K-Zone at the New Afton site: 47.6 million tonnes containing 715,000 ounces of gold and 606 million pounds of copper. A feasibility study for this zone is scheduled to commence in the second half of 2026.

The entire New Afton project contributes significantly to the company’s valuation. Total measured and indicated mineral resources stand at 104.7 million tonnes, holding 1.5 million ounces of gold and 1.2 billion pounds of copper. Over the mine’s complete lifespan, the project is expected to generate an EBITDA of $3.4 billion.

Separately, the life of the Rainy River Mine in Ontario has been extended by two years through 2035. This operation is currently transitioning from open-pit to underground mining and is projected to produce between 230,000 and 275,000 ounces of gold in 2026. Its anticipated lifetime EBITDA is approximately $3.0 billion.

Should investors sell immediately? Or is it worth buying Coeur Mining?

Financial Restructuring and Cost Considerations

However, Rainy River’s projected all-in sustaining costs for 2026 are estimated between $2,150 and $2,350 per gold ounce—higher than Coeur’s other gold-producing assets. This pressure on margins persists even though the company’s planning assumes a long-term gold price of $4,550 per ounce.

Concurrently, Coeur is restructuring the legacy debt assumed from New Gold. The company has launched a private exchange offer for $400 million in outstanding 6.875% Senior Notes due 2032. The proposal involves swapping these existing bonds for new Coeur securities plus a cash payment, accompanied by a relaxation of previous restrictive covenants.

For exploration and reinvestment, Coeur has budgeted roughly $160 million in 2026. This is in addition to approximately $500 million earmarked for ongoing and new development projects, including expansions at Rochester and added capacity at Kensington. The equity currently trades around 31% below its 52-week high of €23.12, reflecting market skepticism regarding the pace of integration for its new assets.

Ad

Coeur Mining Stock: Buy or Sell?! New Coeur Mining Analysis from March 25 delivers the answer:

The latest Coeur Mining figures speak for themselves: Urgent action needed for Coeur Mining investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Coeur Mining: Buy or sell? Read more here...

Tags: Coeur Mining
Kennethcix

Kennethcix

Related Posts

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Ocugen Stock
Analysis

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Next Post
Battalion Oil Stock

Battalion Oil Navigates Debt and Operational Overhaul

IBM Stock

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Realty Income Stock

Realty Income's Strategic Financing Defies High Interest Rate Environment

Recommended

Amazon Stock

Amazon Faces Regulatory Setback While Pushing AI and Retail Expansion

6 months ago
Energy Vault Holdings Stock

Energy Vault’s Strategic Pivot Gains Momentum with Major Texas Acquisition

5 months ago
COREWEAVE INC-CL A Stock

CoreWeave Shares Face Critical Earnings Test

5 months ago
Uranium Energy Stock

Uranium Energy Stock: A Market Paradox

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Trending

Energiekontor Stock
Energy & Oil

Energiekontor Stock Gains Momentum from Policy Shifts

by Rodolfo Hanigan
March 25, 2026
0

While Energiekontor's share price has faced significant headwinds this year, declining roughly 12% since January and over...

Bionxt Solutions Stock

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Energiekontor Stock Gains Momentum from Policy Shifts
  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com